Pfizer Inc. (NYSE:PFE)

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer’s Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Pfizer Inc. (NYSE:PFE)’s Financial Overview

Pfizer Inc. (NYSE:PFE) surged 1.2% yesterday to close its trading session at $31.92. The company has 1 year Price Target of $37.86. Pfizer Inc. has 52-Week high of $37.39 and 52-Week Low of $28.25. The stock touched its 52-Week High on Aug 1, 2016 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 21.63 Million shares yesterday. The firm shows the market capitalization of $193.7 Billion.

Pfizer Inc. (NYSE:PFE) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.61/share against the analyst consensus estimate of $0.62/share. The difference between the actual and expected EPS is $-0.01 a share with a surprise factor of -1.6%.

The firm is trading with SMA20 of 1.75 Percent, SMA50 of -1.1 Percent and SMA200 of -2.4 percent. Pfizer Inc. has P/S value of 3.64 while its P/B value stands at 3.06. Similarly, the company has Return on Assets of 3.6 percent, Return on Equity of 9.7 percent and Return on Investment of 7.3 Percent. The company shows Gross Margin and Operating Margin of 76.6 percent and 15.1 percent respectively.

Many brokerage firms are involved in issuing their ratings on Pfizer Inc. (NYSE:PFE). On 2-Nov-16 Argus Downgrade Pfizer Inc. Stock  to Hold. Another firm also rated the stock on 13-Oct-16 where Jefferies Downgrade the stock to Hold.

The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 21 analysts offering 12-month price forecasts for Pfizer have a median target of 38.00, with a high estimate of 53.00 and a low estimate of 33.00. The median estimate represents a +19.05% increase from the last price of 31.92.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Vipshop Holdings Limited (NYSE:VIPS)

Vipshop Holdings Ltd. is an online discount retailer for brands. The Company offers branded products to consumers in China through flash sales on its vipshop.com website. It offers a wide selection of various famous branded discount products including apparel for women, men and children, fashion goods, cosmetics, home goods and other lifestyle products, through its website. Vipshop Holdings Ltd. is headquartered in Guangzhou.

Vipshop Holdings Limited (NYSE:VIPS)’s Financial Outlook

The 25 analysts offering 12-month price forecasts for Vipshop Holdings Ltd have a median target of 19.00, with a high estimate of 23.00 and a low estimate of 14.10. The median estimate represents a +65.79% increase from the last price of 11.46.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Vipshop Holdings Limited has a Consensus Recommendation of 1.5. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -0.35% and closed its last trading session at $11.46. The company has the market capitalization of $6.74 Billion. The stock has 52-week high of $17.53 and 52-Week low of $10.21. The firm touched its 52-Week high on Dec 15, 2015 and 52-Week low on May 23, 2016. The company has volume of 21.26 Million shares. The company has a total of 587.92 Million shares outstanding.

Vipshop Holdings Limited (NYSE:VIPS) in the last quarter reported its actual EPS of $1.12/share where the analyst estimated EPS was $0.99/share. The difference between the actual and Estimated EPS is $0.13. This shows a surprise factor of 13.1 percent.

The company has YTD performance of -24.95 percent. Beta for Vipshop Holdings Limited stands at 1.72 while its ATR (average true range) is 0.71. The company has Weekly Volatility of 6.59%% and Monthly Volatility of 5.19%%.

Vipshop Holdings Limited has distance from 20-day Simple Moving Average (SMA20) of -12.31%, Distance from 50-Day Simple Moving Average of -17.89 percent and Distance from 200-Day Simple Moving Average of -12.61%.

The Company currently has ROA (Return on Assets) of 9.3 percent, Return on Equity (ROE) of 43.6 Percent and Return on Investment (ROI) of 15.7% with Gross margin of 24.3 percent and Operating & Profit margin of 4.2% and 3.6% respectively.

 

SHARE